Feeds

Bill Gates donates $258m to fight bugs

Mastering malaria not malware

Top 5 reasons to deploy VMware with Tegile

Microsoft billionaire Bill Gates has pledged $258.3m (£145m) to the fight against malaria, describing the disease which claims the lives of an estimated 2,000 African children each day as a "forgotten epidemic".

A trio of grants from the Bill & Melinda Gates Foundation will support research and development on a malaria vaccines, new drugs, and improved mosquito control methods.

"Millions of children have died from malaria because they were not protected by an insecticide-treated bed net, or did not receive effective treatment," said Gates. "If we expand malaria control programs, and invest what’s needed in R&D, we can stop this tragedy."

Drug resistance has rendered the cheapest and most widely-used anti malarial drugs useless in many parts of Africa, hence the need for more research into more effective malaria control tools. The Gates Foundation donation will support three projects over five years (as follows):

  • $107.6m to the PATH Malaria Vaccine Initiative (MVI) to work with GlaxoSmithKline Biologicals and African investigators to complete testing and development of an anti-malaria vaccine candidate
  • $100m to the Medicines for Malaria Venture (MMV) to work on anti-malaria drug research
  • $50.7m to the Innovative Vector Control Consortium (IVCC), led by the Liverpool School of Tropical Medicine, to fast-track development of improved insecticides and other mosquito control methods

Each recipient of the Gates Foundation's grant has developed a plan to make its anti-malaria tools accessible and affordable for developing countries. The Gates Foundation's cash pledges follows a new study by the Malaria R&D Alliance, an international coalition of malaria research groups, will reports that global funding for malaria R&D last year amounted to an inadequate $323m – less than 0.3 per cent of total health research spending worldwide. "For far too long, malaria has been a forgotten epidemic. It’s a disgrace that the world has allowed malaria deaths to double in the last 20 years, when so much more could be done to stop the disease," the Microsoft founder said. ®

Top 5 reasons to deploy VMware with Tegile

More from The Register

next story
Renewable energy 'simply WON'T WORK': Top Google engineers
Windmills, solar, tidal - all a 'false hope', say Stanford PhDs
SEX BEAST SEALS may be egging each other on to ATTACK PENGUINS
Boffin: 'I think the behaviour is increasing in frequency'
Post-pub nosh neckfiller: The MIGHTY Scotch egg
Off to the boozer? This delicacy might help mitigate the effects
I'M SO SORRY, sobs Rosetta Brit boffin in 'sexist' sexy shirt storm
'He is just being himself' says proud mum of larger-than-life physicist
NASA launches new climate model at SC14
75 days of supercomputing later ...
The next big thing in medical science: POO TRANSPLANTS
Your brother's gonna die, kid, unless we can give him your, well ...
Britain's HUMAN DNA-strewing Moon mission rakes in £200k
3 days, and Kickstarter moves lander 37% nearer takeoff
prev story

Whitepapers

Choosing cloud Backup services
Demystify how you can address your data protection needs in your small- to medium-sized business and select the best online backup service to meet your needs.
A strategic approach to identity relationship management
ForgeRock commissioned Forrester to evaluate companies’ IAM practices and requirements when it comes to customer-facing scenarios versus employee-facing ones.
10 threats to successful enterprise endpoint backup
10 threats to a successful backup including issues with BYOD, slow backups and ineffective security.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
Internet Security Threat Report 2014
An overview and analysis of the year in global threat activity: identify, analyze, and provide commentary on emerging trends in the dynamic threat landscape.